Lalwani Nikhil 4
4 · ANI PHARMACEUTICALS INC · Filed Nov 27, 2024
Insider Transaction Report
Form 4
Lalwani Nikhil
DirectorPRESIDENT & CEO
Transactions
- Sale
Common Stock
2024-11-26$57.95/sh−30,000$1,738,500→ 373,859 total - Exercise/Conversion
Stock Option (right to buy)
2024-11-26$29.00/sh−30,000$870,000→ 138,027 totalExercise: $29.00Exp: 2030-09-08→ Common Stock (30,000 underlying) - Exercise/Conversion
Common Stock
2024-11-26$29.00/sh+30,000$870,000→ 403,859 total - Sale
Common Stock
2024-11-26$58.30/sh−3,481$202,942→ 370,378 total
Footnotes (3)
- [F1]The shares were sold in multiple trades at prices ranging from $57.76 to $58.55. The price reported above reflects the weighted average sales price.
- [F2]The shares were sold in multiple trades at prices ranging from $58.18 to $58.61. The price reported above reflects the weighted average sales price.
- [F3]25% of the total options vested on each of September 8, 2021, September 8, 2022, September 8, 2023 and September 8, 2024.